Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) — Cash Flow Reinvestment Rate
Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) has a Cash Flow Reinvestment Rate of 0.63x as of December 2025, reinvesting ₫135.54 Billion (capex ₫135.54 Billion ) from operating cash flow of ₫213.49 Billion. Explore how much does Binh Dinh Pharmaceutical and Medical Equ reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Binh Dinh Pharmaceutical and Medical Equipment JSC Cash Flow Reinvestment Rate (2020–2025)
Historical reinvestment intensity for Binh Dinh Pharmaceutical and Medical Equipment JSC across 6 annual periods. Also explore Binh Dinh Pharmaceutical and Medical Equ balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Binh Dinh Pharmaceutical and Medical Equipment JSC (2020–2025)
Year-by-year capital reinvestment analysis for Binh Dinh Pharmaceutical and Medical Equipment JSC. For live market cap and broader valuation context, see DBD company net worth.
| Year | Reinvestment Rate | Total Reinvested (VND) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.13x | ₫693.35 Billion | ₫615.19 Billion | ₫408.57 Billion | ▲ +13.3% |
| 2024 | 0.99x | ₫263.38 Billion | ₫264.73 Billion | ₫148.75 Billion | ▲ +17.5% |
| 2023 | 0.85x | ₫248.93 Billion | ₫293.99 Billion | ₫133.69 Billion | ▼ -41.9% |
| 2022 | 1.46x | ₫240.52 Billion | ₫165.01 Billion | ₫82.83 Billion | ▲ +14.3% |
| 2021 | 1.27x | ₫149.86 Billion | ₫117.57 Billion | ₫54.64 Billion | ▲ +273.1% |
| 2020 | 0.34x | ₫72.73 Billion | ₫212.91 Billion | ₫59.73 Billion | — |